Ultrastructural examination of renal tubular epithelial cells and hepatocytes in the course of chronic cyclosporin a treatment-a possible link to oxidative stress

Ultrastructural Pathology

Volumn 37, Issue 5, 2013, Pages 332-339

  Korolczuk, Agnieszka ^a   Maciejewski, Mariusz ^a   Czechowska, Grazyna ^a   Orzeł Pankowska, Monika ^b  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b Cormay SA ^*  (Poland)

Author keywords

Cyclosporin A; Kidney; Liver; Mitochondria

Indexed keywords

BIOLOGICAL MARKER; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ANIMAL; APOPTOSIS; BLOOD; CONFERENCE PAPER; DRUG EFFECT; ENDOPLASMIC RETICULUM; KIDNEY TUBULE; LIVER CELL; LYSOSOME; MALE; METABOLISM; MITOCHONDRIAL MEMBRANE; MITOCHONDRION SWELLING; OXIDATIVE STRESS; RAT; TIME; ULTRASTRUCTURE; WISTAR RAT;

ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; CYCLOSPORINE; ENDOPLASMIC RETICULUM; HEPATOCYTES; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TUBULES; LYSOSOMES; MALE; MITOCHONDRIAL MEMBRANES; MITOCHONDRIAL SWELLING; OXIDATIVE STRESS; RATS; RATS, WISTAR; TIME FACTORS;

EID: 84884630721     PISSN: 01913123     EISSN: 15210758     Source Type: Journal    
DOI: 10.3109/01913123.2013.810686     Document Type: Conference Paper

References (57)

1. Stahelin HF. The history of cyclosporin A (Sandimmune) revisited: another point of view. Experientia 1996;52: 5-13.
2. Bobadilla NA, Tapia E, Franco M, et al. Role of nitric oxide in renal hemodynamic abnormalities of cyclosporin nephrotoxicity. Kidney Int 1994;46: 773-9.
3. Feria I, Pichardo I, Juarez P, et al. Therapeutic benefits of spironolactone in experimental chronic cyclosporine nephrotoxicity. Kidney Int 2003;63: 43-52.
4. McNally PG, Feehally J. Pathophysiology of cyclosporin A nephrotoxicity: experimental and clinical observations. Nephrol Dial Transplant 1992;7: 791-804.
5. Burdmann EA, Takeshi F, Yu AL, Bennet WM. Cyclosporine nephrotoxicity. Semin Nephrol 2003;23: 465-76.
6. Bobadilla NA, Gamba G. New insights into the pathophysiology of cyclosporine nephrotoxicity: a role of aldosterone. Am J Physiol Renal Physiol 2007;293: 2-9.
7. Bennett WM, DeMattos A, Meyer M, et al. Chronic cyclosporine nephropathy: the Achilles' heel of immunosuppressive therapy. Kidney Int 1996;50: 1089-100.
8. Atakan A, Arikan H, Macunluoglu B, et al. Renal protective effects of leucotriene receptor blockers in an experimental model of cyclosporine nefrotoxicity. Transplant Proc 2008;40: 279-84.
9. Shehata M, Cope GH, Johnson TS. CsA enhances the expression of TGF beta1 in the juxtraglomerular cells of the rat kidney. Kidney Int 1995;48: 1487-95.
10. Young BA, Burdmann EA, Johnson RJ. Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephrotoxicity. Kidney Int 1995;48: 439-49.
11. Shihab FS, Andoh TF, Tanner AM, et al. Role of TGF beta 1 in experimental chronic CsA nephropathy. Kidney Int 1996; 49: 1141-5.
12. Thomas SE, Andoh TF, Pichler RH. Accelerated apoptosis characterizes CsA associated interstitial fibrosis. Kidney Int 1998;53: 897-908.
13. Parra Cid T, Garcia Conejo JR, Carballo Alvarez F, DeArriba G. Antioxidant nutrients protect against cyclosporine A nephrotoxicity. Toxicology 2003;189: 99-111.
14. Rezzani R, Rodella L, Buffoli B. Change in renal hemeoxygenase expression in cyclosporine A-induced injury. J Histochem Cytochem 2005;53: 105-12.
15. Amudha G, Josephine A, Varalakshmi P. Role of lipoic acid in reducing the oxidative stress induced by cyclosporine A. Clin Chim Acta 2006;372: 134-9.
16. Hagar HH, El Etter E, Arafa M. Taurine attenuates hypertension and renal dysfunction induced by cyclosporine in rats. Clin Exp Pharmacol Physiol 2006;33: 189-96.
17. Sonaje K, Italia L, Sharma G, et al. Development of biodegradable nanoparticles for oral delivery of ellagic acid and evaluation of their antioxidant efficacy against cyclosporine A-induced nephrotoxicity in rats. Pharm Res 2007;24: 899-908.
18. Wongmekiat O, Leelarugrayub N, Thamprasert K. Beneficial effect of shallot (Allium ascalonicum L.) extract on cyclosporine nephrotoxicity in rats. Food Chem Toxicol 2008;46: 1844-50.
19. Zhong Z, Li X, Yamashina S, et al. Cyclosporin A causes a hypermetabolic state and hypoxia in the liver: prevention by dietary glycine. J Pharmacol Exp Ther 2001;299: 858-65.
20. Galan AI, Fernandez E, Moran D, et al. Cyclosporine a hepatotoxicity: effect of prolonged treatment with cyclosporine on biliary lipid secretion in the rat. Clin Exp Pharmacol Physiol 1995;22: 260-5.
21. Hillebrand G, Castro LA, Habersetzer R, et al. Chronic cyclosporine hepatotoxicity after renal transplantation. Transplant Proc 1999;18: 1020-2.
22. Bohme M, Muller M, Leiler I, et al. Cholestasis caused by inhibition of the adenosine triphosphate-dependent bile salt transport in rat liver. Gastroenterology 1994;107: 255-65.
23. Stapf V, Thalhammer T, Huber R, et al. Inhibition of rhodamine 123 secretion by cyclosporin A as a model of Pglycoprotein mediated transport in liver. Anticancer Res 1994;14: 581-5.
24. Roman ID, Monte MJ, Gonzalez-Buitrago JM, et al. Inhibition of hepatocytary vesicular transport by cyclosporin A in the rat: relationship with cholestasis and hyperbilirubinemia. Hepatology 1990;12: 83-91.
25. Wolf A, Trendelenburg CF, Diez-Fernandez C, et al. Cyclosporine A-induced oxidative stress in rat hepatocytes. J Pharmacol Exp Ther 1997;280: 1328-34.
26. Jimenez R, Galan AI, Gonzalez de Buitrago JM, et al. Glutathione metabolism in cyclosporine a-treated rats: dose-and time-related changes in liver and kidney. Clin Exp Pharmacol Physiol 2000;27: 991-6.
27. Hagar HH. The protective effect of taurine against cyclosporine A-induced oxidative stress and hepatotoxicity in rats. Toxicol Lett 2004;151: 335-43.
28. Tariq M, Morais CH, Sobki S, et al. N-Acetylcysteine attenuates cyclosporin-induced nephrotoxicity in rats. Nephrol Dial Transplant 1999;14: 923-9.
29. Mohamadin AM, El-Beshbishy HA, El-Mahdy MA. Green tea extract attenuates cyclosporine A-induced oxidative stress in rats. Pharm Res 2005;51: 51-7.
30. Fasel J, Ryffel B, Mihatch MJ. Light and electron microscopic changes in the kidney of Wistar rats following treatment with cyclosporine A. Ultrastruct Pathol 1987;11: 435-48.
31. Kim YJ, Suh KS. Light microscopic and electron microscopic features of cyclosporine nephrotoxicity in rats. J Kor Med Sci 1995;10: 352-9.
32. Nacar A, Kiyici H, Ogus E, et al. Ultrastructural examination of glomerular and tubular changes in renal allografts with cyclosporine toxicity. Renal Failure 2006;28: 543-7.
33. Hakan A, Onem Y, Aydinoz S, et al. Effect of hyperbaric oxygen on cyclosporine-induced nephrotoxicity and oxidative stress in rats. Renal Failure 2007;29: 495-501.
34. DeHornedo JP, De Arriba G, Fernandez MC, et al. Cyclosporin A causes oxidative stress and mitochondrial dysfunction in tubular renal cells. Nefrologia 2007;27: 565-73.
35. Serkova NJ, Christians U, Benet LZ. Biochemical mechanisms of cyclosporine neurotoxicity. Mol Interv 2004;4: 97-107.
36. Jeon SH, Piao YJ, Choi KJ, et al. Prednisolone suppresses cyclosporine A-induced apoptosis but not cell cycle arrest in MDCK cells. Arch Biochem Biophys 2005;435: 382-92.
37. Nishida M, Ogawa H, Tamai M, et al. Role of hydrogen peroxide in cyclosporine-induced renal tubular cell (LLC-PK1) injury. J Pharmacol Sci 2003;91: 255-8.
38. Jennings P, Koppelstaetter C, Aydin S, et al. Cyclosporine A induces senescence in renal tubular epithelial cells. Am J Physiol Renal Physiol 2007;293: 831-8.
39. Tutanc M, Arica V, Yilmaz N, et al. Effects of erdosteine on cyclosporine-A-induced nephrotoxicity. Hum Exp Toxicol 2012;31: 565-73.
40. Roy MK, Takenaka M, Kobori M, et al. Apoptosis, necrosis and cell proliferation-inhibition by cyclosporine A in U937 cells (a human monocytic cell line. Pharmacol Res 2006;22: 293-302.
41. Carvahlo da Costa M, De Castro I, Cuvello Neto AL, et al. Cyclosporin A tubular effects contribute to nephrotoxicity: role for Ca2 and Mg2 ions. Nephrol Dial Transplant 2003; 18: 2262-8.
42. Zhou YH, Shi D, Yuan B, et al. Mitochondrial ultrastructure and release of proteins during liver regeneration. Indian J Med Res 2008;128: 157-64.
43. Palomero J, Galan AI, Munoz ME, et al. Effects of aging on the susceptibility to the toxic effects of cyclosporin A in rats: changes in liver glutathione and antioxidant enzymes. Free Radic Biol Med 2001;30: 836-45.
44. Grub S, Persohn E, Trommer WE, Wolf A. Induction of apoptosis by the O-hydroxyethyl-D-(Ser)(8)-cyclosporine A derivative SDZ IMM 125 in rat hepatocytes. J Pharmacol Exp Ther 2000;293: 24-32.
45. Grub S, Trommer WE, Wolf A. Role of antioxidants in the O-hydroxyethyl-D-(Ser)8-cyclosporine A (SDZ IMM125)-induced apoptosis in rat hepatocytes. Biochem Pharmacol 2002;64: 1725.
46. Leelavinothan Pari, Ramasamy Sivasankari. Effect of ellagic acid on cyclosporine A-induced oxidative damage in the liver of rats. Fund Clin Pharmacol 2008;22: 395-401.
47. Durak I, Ozbek H, Elgun S. Cyclosporine reduces hepatic antioxidant capacity: protective roles of antioxidants. Int Immunopharmacol 2004;4: 469-73.
48. Kaya H, Koc A, Sogut S, et al. The protective effect of N-acetylcysteine against cyclosporine A-induced hepatotoxicity in rats. J Appl Toxicol 2008;28: 15-20.
49. Erarslan E, Ekiz F, Uz B, et al. Effects of erdosteine on cyclosporine-A-induced hepatotoxicity in rats. Drug Chem Toxicol 2011;34: 32-7.
50. Dykens JA, Will Y. Drug-induced Mitochondrial Dysfunction. New Jersey: Wiley; 2008.
51. Circu ML, Aw TY. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol 2010;48: 749-62.
52. Moran D, Gonzalez-Buitrago JM, Fernandez E, et al. Inhibition of biliary gluthatione secrection by cyclosporine A in the rat: possible mechanism and role in the cholestasis induced by drug. J Hepatol 1998;29: 68-77.
53. Chan FKL, Zhang Y, Lee SS, Shaffer EA. The effects of liver transplantation and cyclosporine on bile formation and lipid conmposition. J Hepatol 1998;28: 329-36.
54. Galan AI, Munoz E, Jimenez R. S-adenosylmethionine protects against cyclosporine A-induced alterations in rat liver plasma membrane fluidity and functions. J Pharmacol Exp Therap 1999;290: 774-81.
55. Faulds D, Goa KL, Benfield P. Cyclosporin A: a review of its pharmacodynamics and pharmacokinetics properties, and therapeutic use in immunoregulatory disorders. Drugs 1993;45: 953-1040.
56. Backman L, Appelkvist EL, Dallner G. Influence of cyclosporine A on protein synthesis in rat liver. Exp Mol Pathol 1988;49: 38-49.
57. Otera H, Mihara K. Mitochondrial dynamics: functional link with apoptosis. Int J Cell Biol 2012;2012: 821676.